Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University, Govt. of NCT of Delhi, New Delhi, India.
Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
Recent Pat Nanotechnol. 2022;16(2):107-127. doi: 10.2174/1872210515666210216085831.
Synthetic polymers present disadvantages such as high cost, limited availability, safety concerns, environmental hazards and accumulation in body. Lignin, an aromatic biopolymer, is highly abundant and offers various advantages including cost-effectiveness, biocompatibility and biodegradability. It also possesses various pharmacological activities including antioxidant, antibacterial, anticancer and UV protection, thus lignin has become a popular biopolymer in recent years and is no more considered as bio-waste rather extensive research is been carried out on developing it as drug carrier. Lignin also has non-biomedical applications including dispersing agents, surfactants, detergent/ cleaning agents, energy storage, etc. Methods: This review compiles patents granted on production of technical lignin, different lignin therapeutic carriers and its biomedical and non-biomedical applications. The literature is collected from recent years including both articles as well as patents and is carefully analyzed and compiled in an easy to comprehend pattern for guiding future research.
The reviewed patents and articles highlighted the advancement made in lignin isolation and valorization. Numerous lignin nanoformulations as drug delivery agents or as standalone entities with various pharmacological actions like antibacterial, antioxidant or UV protectant have been reported. As well as industrial applications of lignin as adhesives, insulators or supercapacitors have also made lignin a biopolymer of choice.
Lignin being a bio-inspired polymer has huge potential in commercial applications. New methods of lignin isolation from lignocellulosic biomass including physical pretreatments, solvent fraction, and chemical and biological pretreatment have been widely patented. Several micro/nano lignin formulations with improved and controllable reactivity like nanocontainers, nanocapsules, nanoparticles have also been reported recently. Also, various pharmacological properties of lignin have also been explored, thus valorization of lignin is a hot topic of hour.
合成聚合物存在成本高、可用性有限、安全性问题、环境危害和在体内积累等缺点。木质素是一种芳香族生物聚合物,具有成本效益、生物相容性和可生物降解性等多种优点。它还具有抗氧化、抗菌、抗癌和抗紫外线等多种药理活性,因此近年来木质素已成为一种流行的生物聚合物,不再被视为生物废物,而是广泛开展了将其开发为药物载体的研究。木质素还具有非生物医学应用,包括分散剂、表面活性剂、洗涤剂/清洁剂、储能等。
本综述汇编了有关生产技术木质素、不同木质素治疗载体及其生物医学和非生物医学应用的专利。文献来自近年来的研究,包括文章和专利,并进行了仔细分析和编译,以便以易于理解的方式为未来的研究提供指导。
综述的专利和文章突出了木质素分离和增值方面的进展。已经报道了许多木质素纳米制剂作为药物递送剂或作为具有各种药理作用的独立实体,如抗菌、抗氧化或抗紫外线保护剂。此外,木质素作为粘合剂、绝缘体或超级电容器的工业应用也使木质素成为首选的生物聚合物。
木质素作为一种生物启发聚合物,在商业应用中具有巨大的潜力。从木质纤维素生物质中分离木质素的新方法,包括物理预处理、溶剂分级、化学和生物预处理,已被广泛专利。最近还报道了几种具有改进和可控反应性的微/纳米木质素制剂,如纳米容器、纳米胶囊、纳米颗粒。此外,还探索了木质素的各种药理特性,因此木质素的增值是当前的热门话题。